Asymptomatic hypoxia in COVID-19 is associated with poor outcome

Philippe Brouqui (1) , Sophie Amrane (1) , Matthieu Million (1) , Sébastien Cortaredona (2) , Philippe Parola (2) , Jean-Christophe Lagier (1) , Didier Raoult (1)

1 MEPHI - Microbes évolution phylogénie et infections
2 VITROME - Vecteurs - Infections tropicales et méditerranéennes

Describe and evaluate the outcome of a coronavirus disease-2019 (COVID-19) patient without shortness of breath.

Keywords: 02 sat; COVID-19; D-dimers; Happy; Hypocapnia; Hypoxemia; Hypoxia; Low dose CT-scan

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases

Philippe Brouqui, Sophie Amrane, Matthieu Million, Sébastien Cortaredona, Philippe Parola, et al.. Asymptomatic hypoxia in COVID-19 is associated with poor outcome. International Journal of Infectious Diseases, 2021, 102, pp.233-238. ⟨10.1016/j.ijid.2020.10.067⟩. ⟨hal-03215632⟩